Tradestie Institutional Equity Comparison Engine
NMTC vs PEN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PEN Overall Edge
PEN Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Penumbra, Inc. (PEN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NMTC trades at N/M Forward P/E with -63.4% operating margin (+16.3% YoY revenue) versus PEN at 53.1x Forward P/E and 12.1% operating margin (+15.6% YoY). In options structure, NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PEN sits in UNCLASSIFIED (96th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
PEN
NMTC N/M vs PEN 53.1x Fwd P/E
Growth & Margin Winner
PEN
Op Margin -63.4% vs 12.1% ยท YoY +16.3% vs +15.6%
Momentum & Technical Winner
PEN
1Y +3.5% vs +12.7% ยท 52W Pos 2% vs 50%
Options & Structure Winner
PEN
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (96th %ile IV)
NMTC
NASDAQ
NeuroOne Medical Technologies Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.65
-3.38% 1D
Market Cap
$6.1M
1M Return
-33.46%
1Y Return
+3.49%
Forward P/E
N/M
Unified AI Score
45.5 / 100
HOLD
Tech 33.0
Fund 51.0
Flow 60.0
Mom 64.0
PEN
NYSE
Penumbra, Inc.
Surgical & Medical Instruments & Apparatus
$319.12
-0.28% 1D
Market Cap
$12.6B
1M Return
-1.8%
1Y Return
+12.7%
Forward P/E
53.1x
Unified AI Score
52.2 / 100
HOLD
Tech 55.0
Fund 56.0
Flow 63.0
Mom 46.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NMTC +3.49%
PEN +12.7%
Spread: +9.21 pp (PEN Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NMTC Revenue | PEN Revenue | NMTC Op. Margin | PEN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $440M | N/A | -0.2% | PEN |
| FY2019 | N/A | $550M | N/A | 8.7% | PEN |
| FY2020 | N/A | $560M | N/A | -6.9% | PEN |
| FY2021 | $0M | $750M | -5735.9% | -1.0% | PEN |
| FY2022 | $0M | $850M | -5860.2% | 0.7% | PEN |
| FY2023 | $0M | $1.06B | -612.3% | 6.9% | PEN |
| FY2024 | $0M | $1.19B | -344.3% | 0.8% | PEN |
| FY2025 | $10M | $1.40B | -46.5% | 13.5% | PEN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NMTC | PEN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.1M | $12.6B | Larger Scale | PEN |
| Trailing P/E Ratio Valuation | N/M | 80.6x | Lower Multiple | PEN |
| Forward P/E Ratio Valuation | N/M | 53.1x | Lower Multiple | PEN |
| Revenue Growth (YoY) Growth | +16.3% | +15.6% | Higher Growth | NMTC |
| Operating Margin (TTM) Profitability | -63.4% | 12.1% | Higher Margin | PEN |
| Net Profit Margin Profitability | -59.7% | 10.1% | Higher Margin | PEN |
| Return on Equity (ROE) Capital Efficiency | -124.7% | 10.7% | Higher ROE | PEN |
| 52-Week Range Position Momentum | 2% ($1โ$5) | 50% ($277โ$362) | Stronger Trend | PEN |
| Beta / 30D Volatility Risk Regime | 1.55ฮฒ ยท 105% Vol | 0.10ฮฒ ยท 10% Vol | Lower Realized Risk | PEN |
| Unified Institutional Score Composite Signal | 45.5 / 100 (HOLD) | 52.2 / 100 (HOLD) | Higher Composite | PEN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NMTC vs PEN Buy Guide
NMTC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
PEN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
96th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NMTC nor PEN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.